Bladder cancer and urine bacteria study
Part of Cancer, Infections, Kidney & urinary clinical trials.
This study looks at bacteria in urine and the bladder to understand if they play a role in causing bladder cancer. Researchers will compare samples from men with bladder cancer and healthy controls.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man over 18 years old.
- You have been diagnosed with bladder cancer using imaging (ultrasound or CT scan) or urine tests.
- Your bladder cancer was confirmed by a biopsy or during a diagnostic procedure (cystoscopy).
- You have not had radiation therapy to your bladder or nearby organs.
- You have not received BCG immunotherapy or chemotherapy directly into your bladder.
- You have not had chemotherapy before surgery for this cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the bacteria in urine of men with bladder cancer to those with other urinary issues and healthy men. For bladder cancer patients, it looks at differences before a planned surgery to remove the bladder.
This study looks at the bacteria in your gut and bladder to understand how they may relate to bladder cancer. It is for men who are having their first tumor removal for suspected bladder cancer, and helps researchers learn if the microbiome plays a role.
This study looks at how the bacteria living in your gut and bladder (your microbiome) might affect the course of non-muscle invasive bladder cancer (NMIBC). By collecting tissue samples, researchers hope to learn if certain bacteria can help predict how the disease will progress or respond to treatment.
This study tests whether a special urine testing approach can better identify and sort risk in people (especially veterans) who were referred to urology for blood in the urine. It may help doctors decide who needs more urgent follow-up and which next steps to take.
This study follows people with urothelial cancer and certain rare genital (genitourinary) cancers over time to learn how these diseases progress. It may help researchers understand patterns of symptoms and outcomes, even if it is not a drug trial.
This study looks at how bacteria and the immune system affect the lower urinary tract. It includes healthy volunteers and people with various urinary conditions, like infections or bladder pain.
Hear when a new Microbiota in Patients With Urinary Bladder Carcinoma in Urine and Cancer Tissues trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.